Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Drugs & Aging
Published in: Drugs & Aging 5/2007

01-05-2007 | Review Article

Optimal Management of Asthma in Elderly Patients

Strategies to Improve Adherence to Recommended Interventions

Authors: Ms Dianne P. Goeman, Jo A. Douglass

Published in: Drugs & Aging | Issue 5/2007

Login to get access

Abstract

Adherence to asthma medications presents a problem in all age groups, and older people with chronic illnesses such as asthma also have multiple co-morbidities and consequently complex healthcare needs. It has been suggested that older people are also less likely to adhere to medication and treatment than younger people. Although the prevalence of asthma in older people is similar to that of the general population, over two-thirds of those who die from asthma are >50 years of age and there is strong evidence for under-diagnosis. Clinicians therefore face specific challenges in providing healthcare with respect to both asthma diagnosis and treatment in older age groups. Non-adherence to medication can be defined as either ‘intentional’ or ‘unintentional’. Unintentional non-adherence is more likely to be associated with sociodemographic or physical barriers to the use of medication. Intentional non-adherence results from the balance of individual reasoning of risks versus the benefits of taking medication and acceptance of asthma diagnosis. Intentional non-adherence can be addressed through strategies that influence health beliefs and concerns about the adverse effects of medicine. Unintentional adherence can be addressed by assessing and educating the patient in relation to device use and providing education and clear written instructions about medication requirements. However, some barriers to medication use, such as financial ones, may be systematic. Most studies of medication use, efficacy, adverse effects and adherence in patients with asthma primarily involve younger people. Studies of strategies to improve asthma adherence outcomes specifically in older people are urgently needed.
Literature
1.
Global Initiative for Asthma (GINA). Asthma management and prevention: a practical guide for public health officials and health care professionals. London: Imperial College, GINA, 2001
2.
Australian Centre for Asthma Monitoring. Asthma in Australia 2005. AIHW Asthma Series 2. AIHW cat. no. ACM 6. Canberra (ACT): AIHW, 2005
3.
Campbell M, Cogman G, Holgate S, et al. Age specific trends in asthma mortality in England and Wales, 1983–95: results of an observational study. BMJ 1997; 314: 1439–41PubMedCrossRef
4.
Mannino DM, Homa DM, Akinbami LJ, et al. Surveillance for asthma-United States, 1980–1999. MMWR Surveill Summ 2002 Mar 29; 51(1): 1–13
5.
Enright P, Kronmal R, Higgins M, et al. Prevalence and correlates of respiratory symptoms and disease in the elderly. Chest 1994; 106: 827–34PubMedCrossRef
6.
Kitch B, Levy B, Fanta C. Late onset asthma: epidemiology, diagnosis and treatment. Drugs Aging 2000; 17: 385–97PubMedCrossRef
7.
Wilson D, Appleton S, Adams R, et al. Undiagnosed asthma in older people: an underestimated problem. Med J Aust 2005; 183(1 Suppl.): S20–2PubMed
8.
Krishnan V, Diette G, Rand C, et al. Mortality in patients hospitalized for asthma exacerbations in the United States. Am J Respir Crit Care Med 2006; 174: 633–8PubMedCrossRef
9.
Guidelines for the diagnosis and management of asthma. Expert Panel Report II. NIH publication no. 97-4501. Bethesda (MD): National Institutes of Health, National Heart, Lung and Blood Institute, 1997
10.
Enright P. The diagnosis and management of asthma is much tougher in older patients. Curr Opin Allergy Clin Immunol 2002; 2: 175–81PubMedCrossRef
11.
12.
Renwick D, Connolly M. Improving outcomes in elderly patients with asthma. Drugs Aging 1999; 14(1): 1–9PubMedCrossRef
13.
Masood D, Cheriyan S, Patterson R. Management of asthma in the geriatric population. Gerontology 1996; 42: 183–9PubMedCrossRef
14.
Weiss S, Petty T. Special challenges in managing asthma in the elderly: keys to unmasking a ‘hidden’ ailment. Consultant 1998; 38: 686–90
15.
Barua P, O’Mahony M. Overcoming gaps in the management of asthma in older patients. Drugs Aging 2005; 22: 1029–59PubMedCrossRef
16.
17.
Enright PL, McClelland RL, Newman AB, et al. Underdiagnosis and undertreatment of asthma in the elderly. Chest 1999; 116: 603–13PubMedCrossRef
18.
19.
Walters K, Illiffe S, Orrell M. An exploration of help-seeking behaviour in older people with unmet needs. Fam Pract 2001; 18: 277–82PubMedCrossRef
20.
Moore ST. Marketing ambulatory services to the elderly. J Hosp Mark 1991; 6: 121–9PubMed
21.
Abramson M. Respiratory symptoms and lung function in older people with asthma or chronic obstructive pulmonary disease. Med J Aust 2005; 183(1 Suppl.): S23–5PubMed
22.
23.
24.
Bashoura L, Hanania N. Cough may be the only presenting symptom: confronting the challenges of asthma in the elderly patient. J Respir Dis 2004; 25: 310–6
25.
Asthma management handbook 2002. South Melbourne (VIC): National Asthma Council Australia (NACA), 2002
26.
27.
Campbell DA, Luke CG, McLennan G, et al. Near-fatal asthma in South Australia: descriptive features and medication use. Aust N Z J Med 1996; 26(3): 356–62PubMedCrossRef
28.
Walters JA, Wood-Baker R, Walters EH. Long-acting beta2-agonists in asthma: an overview of Cochrane systematic reviews. Respir Med 2005; 99(4): 384–95PubMedCrossRef
29.
Salpeter S, Buckley N, Ormiston T, et al. Meta-analysis: effect of long-acting β-agonists on severe asthma exacerbations and asthma related deaths. Ann Intern Med 2006; 144: 904–12PubMed
30.
Beasley R, Pearce N, Crane J, et al. Beta-agonists: what is the evidence that their use increases the risk of asthma morbidity and mortality? J Allergy Clin Immunol 1999; 104 (2 Pt 2): S18–30PubMedCrossRef
31.
Newnham D. Asthma medications and their potential adverse effects in the elderly: recommendations for prescribing. Drug Safety 2001; 24: 1065–80PubMedCrossRef
32.
Burgess C, D’Arcy C, Holman J. Adverse drug reactions in older Australians, 1981–2002. Med J Aust 2005; 182: 267–70PubMed
33.
Clark N, Jones P, Keller S, et al. Patient factors and compliance with asthma therapy. Respir Med 1999; 93: 856–62PubMedCrossRef
34.
Gibson P, Powell H, Coughlan J, et al. Limited (information only) patient education programs for adults with asthma. Cochrane Database Syst Rev 2002; (2): CD001005
35.
Douglass J, Aroni R, Goeman D, et al. A qualitative study of action plans for asthma. BMJ 2002; 324: 1003–7PubMedCrossRef
36.
Jones A, Pill R, Adams S. Qualitative study of views of health professionals and patients on guided self-management plans for asthma. BMJ 2000; 321: 1507–10PubMedCrossRef
37.
Radecki S, Cowell W. Health promotion for elderly patients. Fam Med 1990; 22(4): 299–302PubMed
38.
Abramson M, Bailey M, Couper F, et al. Are asthma medications and management related to deaths from asthma? Am J Resp Crit Care Med 2001; 163: 12–8PubMed
39.
Ruffin R, Wilson D, Smith B, et al. Prevalence, morbidity and management of adult asthma in South Australia. Immunol Cell Biol 2001; 79: 191–4PubMedCrossRef
40.
Diette G, Krishnan J, Dominici F, et al. Asthma in older patients: factors associated with hospitalisation. Arch Intern Med 2002; 162: 1123–32PubMedCrossRef
41.
Adams R, Smith B, Ruffin R. Factors associated with hospital admissions and repeat emergency department visits for adults with asthma. Thorax 2000; 55: 566–73PubMedCrossRef
42.
Australian Bureau of Statistics (ABS) 2004–05 National Health Survey: Australian social trends 2006. ABS cat. no. 4102.0. Canberra (ACT): ABS, 2006
43.
Australian Institute of health and Welfare (AIHW). Australia’s health 2002. AIHW cat. no. AUS25. Canberra (ACT): AIHW, 2002
44.
Paltiel AD, Fuhlbrigge AL, Kitch BT, et al. Cost-effectiveness of inhaled corticosteroids in adults with mild-to-moderate asthma: results from the Asthma Policy Model. J Allergy Clin Immunol 2001; 108(1): 39–46PubMedCrossRef
45.
Schmier J, Halpern M, Jones M. Effects of inhaled corticosteroids on mortality and hospitalisation in elderly asthma and chronic obstructive pulmonary disease. Drugs Aging 2005; 22: 717–29PubMedCrossRef
46.
Goeman D, Hogan C, Aroni R, et al. Barriers to delivering asthma care: a qualitative study of general practitioners. Med J Aust 2005; 183: 457–60PubMed
47.
Douglass J, Goeman D, Yu E. Asthma 3+ Visit Plan: a qualitative evaluation. Intern Med J 2005; 35: 457–62PubMedCrossRef
48.
Armour C, Bosnic-Anticevich S, Saini B, et al. Pharmacists improving health care for asthma [abstract no. 120]. Proceedings of TSANZ 2006 Annual Scientific Meeting; 2006 Mar 24–29; Canberra (ACT)
49.
Janson S, Hardie G, Fahy J, et al. Use of biological markers of airway inflammation to detect the efficacy of nurse-delivered asthma education. Heart Lung 2001; 30: 39–46PubMedCrossRef
50.
Centers for Disease Control and Prevention (CDC). Asthma mortality and hospitalization among children and young adults — United States, 1980–1993. MMWR Morb Mortal Wkly Rep 1996; 45: 350–3
51.
52.
Reddel H, Ware S, Marks G, et al. Differences between asthma exacerbations and poor asthma control. Lancet 1999 Jan 30; 353(9150): 364–9PubMedCrossRef
53.
Robertson C, Rubinfeld A, Bowes G. Deaths from asthma in Victoria: a 12-month survey. Med J Aust 1990; 152: 511–7PubMed
54.
Krishnan JA, Riekert KA, McCoy JV, et al. Corticosteroid use after hospital discharge among high-risk adults with asthma. Am J Respir Crit Care Med 2004; 170: 1281–5PubMedCrossRef
55.
Biais L, Ernst P, Boivin JF, et al. Inhaled corticosteroids and the prevention of readmission to hospital for asthma. Am J Respir Crit Care Med 1998; 158(1): 126–32
56.
Hartert T, Togias A, Meilen B, et al. Under utilisation of controller and rescue medication among older adults with asthma requiring hospital care. J Am Geriatr Soc 2000; 48: 651–7PubMed
57.
Apter A, Boston R, George M, et al. Modifiable barriers to adherence to inhaled steroids among adults with asthma: it’s not just black and white. J Allergy Clin Immunol 2003; 111: 1219–26PubMedCrossRef
58.
Weinstein A. Should patients with persistent severe asthma be monitored for medication adherence? Ann Allergy Asthma Immunol 2005; 94: 251–7PubMedCrossRef
59.
van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 2003; 20: 229–40PubMedCrossRef
60.
Chapman KR, Walker L, Cluley S, et al. Improving patient compliance with asthma therapy. Respir Med 2000; 94: 2–9PubMedCrossRef
61.
Hippocrates. Decorum, c. 200BC. Quoted in: Sawyer S. Adherence: whose responsibility? In: A decade of coordinated asthma management in Australia. Melbourne (VIC): National Asthma Campaign, 1998: 9–10
62.
Cockburn J. Patient education and strategies to improve adherence. In: Wall R, Jenkins C, editors. Understanding asthma. Sydney (NSW): Maclennan & Petty, 2000
63.
MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging 2005; 22: 231–55PubMedCrossRef
64.
National Asthma Campaign Ltd (NAC). Asthma adherence: a guide for health professionals. South Melbourne (VIC): NAC Ltd, 1999
65.
Haynes RB, McDonald H, Garg AX, et al. Interventions for helping patients to follow prescriptions for medications. Coch-rane Database Syst Rev 2002; (2): CD000011
66.
67.
68.
Higgins N, Regan C. A systematic review of the effectiveness of interventions to help older people adhere to medication regimes. Age Ageing 2004; 44: 224–9CrossRef
69.
Delado P. Approaches to the enhancement of patient adherence to antidepressant medication treatment. J Clin Psychiatry 2000; 61: 6–9
70.
Allen S. Competence thresholds for the use of inhalers in people with dementia. Age Ageing 1997; 26: 83–6PubMedCrossRef
71.
Basheti I, Reddel H, Armour C, et al. Counseling about turbuhaler technique: needs assessment and effective strategies for community pharmacists. Respir Care 2005; 50: 617–23PubMed
72.
Allen S, Prior A. What determines whether an elderly patient can use a metered dose inhaler correctly? Br J Dis Chest 1986; 80: 45–9PubMedCrossRef
73.
Allen S, Harries D. Which inhaler for the elderly asthmatic? Geriatr Med 1989; 19: 61–3
74.
Irwin R, Richardson ND. Side effects with inhaled corticosteroids: the physician’s perception. Chest 2006; 130 (1 Suppl.): S41–53CrossRef
75.
Ullah M, Newman G. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 1981; 36: 523–9PubMedCrossRef
76.
Piette J, Heisler M, Krein S, et al. The role of patient-physician trust in moderating medication nonadherence due to cost pressures. Arch Intern Med 2005; 165: 1749–55PubMedCrossRef
77.
Goeman D, Aroni R, Stewart K, et al. Patients’ views of the burden of asthma: a qualitative study. Med J Aust 2002; 177: 295–9PubMed
78.
Adams S, Pill R, Jones A, et al. Medication, chronic illness and identity: the perspective of people with asthma. Soc Sci Med 1997; 45: 189–201PubMedCrossRef
79.
80.
81.
Byer B, Myers L. Psychological correlates of adherence to medication in asthma. Psychol Health Med 2000; 5: 389–93CrossRef
82.
Wroe AL. Intentional and unintentional non-adherence: a study of decision making. J Behav Med 2002; 25(4): 355–72PubMedCrossRef
83.
Bender BG. Overcoming barriers to non-adherence in asthma treatment. J Allergy Clin Immunol 2002; 109 (6 Suppl.): S554–9PubMedCrossRef
84.
Sin D, Tu J. Under use of inhaled steroid therapy in elderly patients with asthma. Chest 2001; 119: 720–5PubMedCrossRef
85.
Barr G, Somers S, Speizer F, et al. Patient factors and medication guideline adherence among older women with asthma. Arch Intern Med 2002; 162: 1761–8PubMedCrossRef
86.
Osman LM. How do patients’ views about medication affect their self-management in asthma? Patient Educ Couns 1997; 32 (1 Suppl.): S43–9PubMedCrossRef
87.
Horne R. Compliance, adherence, and concordance: implications for asthma treatment. Chest 2006; 130 (1 Suppl.): 65S–72SPubMedCrossRef
88.
Donovan J, Blake D. Patient non-compliance: deviance or reasoned decision-making? Soc Sci Med 1992; 34: 507–13PubMedCrossRef
89.
van Schayck CP, Bijl-Hofland ID, Folgering H, et al. Influence of two different inhalation devices on therapy compliance in asthmatic patients. Scand J Prim Health Care 2002; 20: 126–8PubMedCrossRef
90.
91.
Allen SC, Ragab S. Ability to learn inhaler technique in relation to cognitive scores and tests of praxis in old age. Postgrad Med 2002; 78: 37–9CrossRef
92.
Stevens D, Sharma L, Kesten S. Insurance status and patient behavior with asthma medications. J Asthma 2003; 40: 789–93PubMedCrossRef
93.
Home R, Weinman J, Hankins M. The Beliefs about Medicines Questionnaire (BMQ): the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health 1998; 14: 1–24
94.
Jessop D, Rutter D. Adherence to asthma medications: the role of illness representations. Psychol Health 2003; 18: 595–612CrossRef
95.
Home R, Weinman J. Patients’ beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res 1999; 47: 555–67CrossRef
96.
Home R, Weinman J. Self-regulation and self management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non adherence to preventer medication. Psychol Health 2002; 17: 17–32CrossRef
97.
Jones GK, Bell J, Fehrenbach C, et al. Understanding patient perceptions of asthma: results of the Asthma Control and Expectations (ACE) survey. Int J Clin Pract 2002; 56: 89–93PubMed
98.
Jenkins L, Britten N, Stevenson F, et al. Developing and using quantitative instruments for measuring doctor-patient communication about drugs. Patient Educ Couns 2003; 50: 273–8PubMedCrossRef
99.
Hand CH, Bradley C. Health beliefs of adults with asthma: toward an understanding of the difference between symptomatic and preventive use of inhaler treatment. J Asthma 1996; 33: 331–8PubMedCrossRef
100.
101.
102.
Onyirimba F, Apter AJ, Reisine S, et al. Direct clinician-to-patient feedback discussion of inhaled steroid use: its effect on adherence. Ann Allergy Asthma Immunol 2003; 90: 411–5PubMedCrossRef
103.
104.
Shiffman R, Freudigman M, Brandt C, et al. A guideline implementation system using handheld computers for office management of asthma: effects on adherence and patient outcomes. Pediatrics 2000; 105: 767–73PubMedCrossRef
105.
Levy ML. Organized care in general practice: structure and evaluation. Respir Med 1997; 91: 578–80PubMedCrossRef
106.
Kolbe J. Asthma education, action plans, psychosocial issues and adherence. Can Respir J 1999; 6: 273–80PubMed
107.
Tomlins R, Hope K. Proactive asthma care: the benefits of behavioural change. Aust Fam Physician 2001 Feb; 30(2): 127PubMed
108.
Townsend A, Hunt K, Wyke S. Managing multiple morbidity in mid life: a qualitative study of attitudes to drug use. BMJ 2003; 327: 837–40PubMedCrossRef
109.
George M, Freedman T, Norfleet A, et al. Qualitative research-enhanced understanding of patients’ beliefs: results of focus groups with low income, urban, African American adults with asthma. J Allergy Clin Immunol 2003; 111: 967–73PubMedCrossRef
110.
Schmaling KB, Afari N, Blume A, et al. Assessment of psychological factors associated with adherence to medication regimens among adult patients with asthma. J Asthma 2000; 37: 335–43PubMedCrossRef
111.
Campbell D, Yellowlees P, McLennan G, et al. Psychiatric and medical features of near fatal asthma. Thorax 1995; 50: 254–9PubMedCrossRef
112.
113.
Harrison B. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005; 35: 543–7PubMedCrossRef
114.
Bender B, Milgrom H, Apter A, et al. Adherence intervention research: what have we learned and what do we do next? J Allergy Clin Immunol 2003; 112: 489–94PubMedCrossRef
115.
Elwyn G, Edwards A, Britten N, et al. Doing prescribing: how doctors can be more effective. BMJ 2003; 327: 846–7CrossRef
116.
Stevenson F, Gerrett D, Rivers P, et al. GPs’ recognition of and response to influences on patients’ medicine taking: the implications for communication. Fam Pract 2000; 17: 119–23PubMedCrossRef
117.
Bissell P, May C, Noyce P, et al. From compliance to concordance: barriers to accomplishing a re-framed model of health care interactions. Soc Sci Med 2004; 58: 851–62PubMedCrossRef
118.
Stevenson F, Scambler G. The relationship between medicine and the public: the challenge of concordance. Health 2005; 9: 5–21PubMedCrossRef
119.
Ryan-Woolley BM, Rees JA. Initializing concordance in frail elderly patients via a medicines organizer. Ann Pharmacother 2005; 39: 834–9PubMedCrossRef
120.
121.
Benson J, Britten N. What effects do patients feel from their ICS medication and how do they react? Fam Pract 2006; 23: 80–7PubMedCrossRef
122.
Pound P, Britten N, Morgan M, et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 2005; 61: 133–55PubMedCrossRef
Metadata
Title
Optimal Management of Asthma in Elderly Patients
Strategies to Improve Adherence to Recommended Interventions
Authors
Ms Dianne P. Goeman
Jo A. Douglass
Publication date
01-05-2007
Publisher
Springer International Publishing
Published in
Drugs & Aging / Issue 5/2007
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI
https://doi.org/10.2165/00002512-200724050-00003

Other articles of this Issue 5/2007

Drugs & Aging 5/2007 Go to the issue

Original Research Article

Age-Related Differences in the Prevalence of Potential Drug-Drug Interactions in Ambulatory Dyslipidaemic Patients Treated with Statins

Review Article

Docetaxel in Non-Small Cell Lung Cancer

Leading Article

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis

Leading Article

Intermittent Bisphosphonate Therapy in Postmenopausal Osteoporosis

Review Article

Oral Anticancer Drugs in the Elderly
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits